TrialJournal of the American Society of Nephrology : JASN2013
Cardiovascular effects of sevelamer in stage 3 CKD.
Colin D Chue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this paperpooled ittrialcites it